Industry Veteran and VC Investor Strengthen the BTB Therapeutics Board
2025-02-24
Election of Representative Director and Chief Executive Officer
2024-08-02
Notice of Relocation of Headquarters
2024-07-01
We have received an investment from SMBC Venture Capital.
2024-06-24
Announcement: Appointment of Chief Financial Officer and Representative Director
2024-06-17
The press release from Kyoto University Hospital regarding the start of the Phase II part of an investigator-initiated clinical trial for a new analgesic drug was published.
2024-04-30
We have received an investment from Innovation Kyoto 2021 Investment Limited Partnership with Kyoto University Innovation Capital Corporation (Kyoto iCAP) as a partner with unlimited liability.
2023-10-27
At the general meeting of shareholders held on October 17, 2023, a resolution was passed to elect the following director. Takashi Kiyoizumi, Director (U.S. Development) (New Appointment)
Our part-time director, Prof. Masatoshi Hagiwara, Department of Anatomy and Developmental Biology, Kyoto University, has received the Special Award from the Japanese Society of Toxicology.(Japanese only)
2023-10-05
